Intuniv Tablets Specified Drug Use Results Survey (Adult)

Intuniv Tablets Specified Drug Use Results Survey (Adult) - Intuniv Tablets Specified Drug Use Results Survey (Adult)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040429

Enrollment

750

Registered

2020-06-01

Start date

2020-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit/hyperactivity disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult (18 years or older) AD/HD patients with inexperienced use of Intuniv tablets and written consent on data collection and use in this study

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
(1) Safety Incidence rates of adverse drug reactions, Safety specification items of Intuniv Tablets (2) Efficacy Evaluation of physicians by the ADHD Rating Scale IV (ADHD RS-IV) with adult prompt Japanese Version	—

Countries

Japan

Contacts

Public ContactKatsuaki Shirai

Takeda Pharmaceutical Co., Ltd. PMS Strategic Management, Japan Medical Office

katsuaki.shirai@takeda.com+81-70-2317-1182

Outcome results